ArticleJournal of managed care & specialty pharmacy2023

Disparity in initiation of checkpoint inhibitors among commercially insured and Medicare Advantage patients with metastatic melanoma.

Meng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.